Brokerages Set Herbalife Ltd (NYSE:HLF) Price Target at $17.75

Shares of Herbalife Ltd (NYSE:HLF) have received a consensus recommendation of “Moderate Buy” from the six ratings firms that are currently covering the company, Marketbeat reports. Two research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $17.75.

A number of research analysts have recently issued reports on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Herbalife in a research report on Thursday, January 22nd. Maxim Group assumed coverage on shares of Herbalife in a research report on Tuesday, January 6th. They issued a “buy” rating and a $20.00 price objective on the stock. Mizuho lifted their price objective on shares of Herbalife from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Monday, March 30th. Zacks Research raised shares of Herbalife from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. Finally, Citigroup reaffirmed a “buy” rating and issued a $21.00 price objective (up from $17.00) on shares of Herbalife in a research report on Thursday, February 19th.

Herbalife Stock Up 2.7%

Shares of Herbalife stock opened at $14.26 on Tuesday. The firm’s 50 day moving average price is $16.40 and its 200-day moving average price is $13.20. Herbalife has a 52-week low of $6.20 and a 52-week high of $20.40. The company has a market cap of $1.47 billion, a P/E ratio of 6.48, a PEG ratio of 0.83 and a beta of 0.95.

Herbalife (NYSE:HLF) last issued its quarterly earnings data on Thursday, February 19th. The company reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.48 by ($0.03). Herbalife had a negative return on equity of 35.02% and a net margin of 4.53%.The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.24 billion. During the same period in the previous year, the firm earned $0.36 EPS. The firm’s quarterly revenue was up 6.3% on a year-over-year basis. As a group, equities research analysts forecast that Herbalife will post 1.57 EPS for the current fiscal year.

Institutional Trading of Herbalife

Several large investors have recently bought and sold shares of the stock. Geode Capital Management LLC grew its position in Herbalife by 1.0% during the 4th quarter. Geode Capital Management LLC now owns 2,577,634 shares of the company’s stock worth $33,231,000 after purchasing an additional 25,783 shares during the last quarter. Iridian Asset Management LLC CT grew its position in Herbalife by 9.9% during the 3rd quarter. Iridian Asset Management LLC CT now owns 2,449,155 shares of the company’s stock worth $20,671,000 after purchasing an additional 220,896 shares during the last quarter. Quantedge Capital Pte Ltd grew its position in Herbalife by 5.2% during the 4th quarter. Quantedge Capital Pte Ltd now owns 2,249,683 shares of the company’s stock worth $28,998,000 after purchasing an additional 111,700 shares during the last quarter. Solel Partners LP grew its position in Herbalife by 18.7% during the 2nd quarter. Solel Partners LP now owns 1,669,405 shares of the company’s stock worth $14,390,000 after purchasing an additional 262,614 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Herbalife by 3.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,451,749 shares of the company’s stock worth $18,713,000 after purchasing an additional 52,642 shares during the last quarter.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.